EVALUATION OF NEW ANTIINFECTIVE DRUGS FOR THE TREATMENT OF TYPHOID-FEVER

被引:4
|
作者
CORRADO, ML
DUPONT, HL
COOPERSTOCK, M
FEKETY, R
MURRAY, DM
机构
[1] UNIV TEXAS,SCH MED,HLTH SCI CTR HOUSTON,CTR INFECT DIS,6431 FANNIN,1 728 JFB,HOUSTON,TX 77030
[2] UNIV TEXAS,SCH PUBL HLTH,HOUSTON,TX 77025
[3] UNIV MISSOURI,MED CTR,SCH MED,DEPT PEDIAT,COLUMBIA,MO 65201
[4] UNIV MICHIGAN,MED CTR,DIV INFECT DIS,ANN ARBOR,MI 48109
[5] PROCTER & GAMBLE CO,GEN OFF HLTH CARE,CINCINNATI,OH 45239
[6] ROBERT WOOD JOHNSON PHARMACEUT INST,DIV ANTIINFECT,RARITAN,NJ
关键词
D O I
10.1093/clind/15.Supplement_1.S236
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Typhoid fever is an acute febrile illness caused by Salmonella typhi. The evidence of blood-borne infection required for study entry includes clinical signs and symptoms plus confirmation of the presence of S. typhi in blood or other tissues or body fluids. The preferred study design is prospective and randomized with an active concurrent control. It is preferred that the investigator or an evaluator be blinded to therapy. In general, treatment should be administered for 2 weeks until it is demonstrated that a shorter course is as efficacious and as safe. Follow-up cultures of specimens from sites originally shown to be infected with S. typhi should be performed unless the diagnostic procedure places the patient at unnecessary risk.
引用
收藏
页码:S236 / S240
页数:5
相关论文
共 50 条
  • [1] NEW AND OLD DRUGS FOR TREATING TYPHOID-FEVER
    FINKELSTEIN, R
    MARKEL, A
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1990, 161 (01): : 159 - 159
  • [2] DRUGS FOR TYPHOID-FEVER - REPLY
    SNYDER, MJ
    WOODWARD, WE
    [J]. LANCET, 1977, 1 (8010): : 545 - 546
  • [3] TREATMENT OF TYPHOID-FEVER
    IMBERT, JC
    KABBAGE, M
    KADIRI, M
    [J]. REVUE DU PRATICIEN, 1978, 28 (01): : 29 - &
  • [4] ENOXACIN IN THE TREATMENT OF TYPHOID-FEVER
    AHMED, A
    SALAHUDDIN, N
    AHSAN, T
    AFSAR, S
    NASIR, N
    FAROOQUI, S
    CHAOUDRI, AN
    AKHTAR, MA
    AGHA, I
    NAGI, N
    [J]. CLINICAL THERAPEUTICS, 1992, 14 (06) : 825 - 828
  • [5] TREATMENT OF MULTIRESISTANT TYPHOID-FEVER
    ROWE, B
    WARD, LR
    THRELFALL, EJ
    [J]. LANCET, 1991, 337 (8754): : 1422 - 1422
  • [6] ANTIBIOTIC TREATMENT OF TYPHOID-FEVER
    GEDDES, AM
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1977, 3 (05) : 382 - 383
  • [7] MOXALACTAM IN THE TREATMENT OF TYPHOID-FEVER
    UWAYDAH, M
    VARTIVARIAN, S
    SHATILA, S
    RAAD, I
    HARAKEH, H
    NASSAR, NT
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1986, 30 (02) : 338 - 339
  • [8] CEPHRADINE TREATMENT OF TYPHOID-FEVER
    PARADELIS, AG
    STATHOPOULOS, G
    GRIGORIADOUEDIPIDES, A
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1977, 3 (06) : 627 - 627
  • [9] CEFOPERAZONE FOR TREATMENT OF TYPHOID-FEVER
    RAOULT, D
    GALLAIS, H
    FOSSE, T
    XERIDAT, B
    DAVID, MF
    CASANOVA, P
    [J]. PATHOLOGIE BIOLOGIE, 1984, 32 (5BIS): : 573 - 575
  • [10] TREATMENT OF TYPHOID-FEVER WITH OFLOXACIN
    WANG, F
    GU, XJ
    ZHANG, MF
    TAI, TY
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1989, 23 (05) : 785 - 788